FineMark National Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-1,660
| Closed | -$94K | – | 1470 |
|
|
2015
Q3 | $94K | Buy |
1,660
+115
| +7% | +$6.51K | 0.01% | 475 |
|
|
2015
Q2 | $92K | Buy |
1,545
+179
| +13% | +$10.7K | 0.01% | 506 |
|
|
2015
Q1 | $85K | Sell |
1,366
-2,205
| -62% | -$137K | 0.01% | 528 |
|
|
2014
Q4 | $205K | Sell |
3,571
-2,225
| -38% | -$128K | 0.03% | 341 |
|
|
2014
Q3 | $312K | Buy |
5,796
+50
| +0.9% | +$2.69K | 0.05% | 260 |
|
|
2014
Q2 | $301K | Sell |
5,746
-371
| -6% | -$19.4K | 0.05% | 264 |
|
|
2014
Q1 | $323K | Sell |
6,117
-312
| -5% | -$16.5K | 0.06% | 242 |
|
|
2013
Q4 | $258K | Buy |
6,429
+581
| +10% | +$23.3K | 0.05% | 275 |
|
|
2013
Q3 | $221K | Sell |
5,848
-129
| -2% | -$4.88K | 0.05% | 287 |
|
|
2013
Q2 | $234K | Buy |
+5,977
| New | +$234K | 0.07% | 252 |
|